Carl-Magnus Högerkorp


Born 1970. CEO since 2022.


Carl-Magnus Högerkorp holds a PhD in immunology from Lund University, as well as an MBA from EFL/Lund school of Economics and Management. He brings long and broad experience from pharma and biotech companies, both internationally and nationally. During his career, Dr Högerkorp has for example worked with research and development projects within infectious disease, immuno oncology, regenerative medicine, inflammation and autoimmune diseases. Further, he has held senior positions in several companies such as CEO for Edvince, Canimguide Therapeutics and ImModulate Pharma and CSO at Xintela, where he took part in the introduction of the company on Nasdaq First North Growth Market.

Shares in the company

Carl-Magnus Högerkorp owns 181,673 shares in Cyxone

Malin Lindskog


Born 1992. CFO since 2023.


Malin has studied Business and Administration program at Lund University with a focus on Business Law and Organization and Leadership. She has several years of experience as Controller and office Manager in public biotech companies such as Gabather AB.

Shares in the company

No shares


Rhea Rodeo

CEO assistant/Office Manager

Rhea Rodeo has many years of work experience as HR assistant, Secretary, Administrator, and Project Administrator. Before joining Cyxone, she worked at large international companies in Sweden, such as Westinghouse and IKEA. At Cyxone, Rhea Rodeo is responsible for general administration and provides support and assistance to the CEO and CFO.

Phone: +46 708 88 21 72